M&A Deal Summary

Certara Acquires Synchrogenix Information Strategies

On April 2, 2014, Certara acquired medical products company Synchrogenix Information Strategies

Acquisition Highlights
  • This is Certara’s 1st transaction in the Medical Products sector.
  • This is Certara’s 2nd transaction in the United States.
  • This is Certara’s 1st transaction in Delaware.

M&A Deal Summary
Date 2014-04-02
Target Synchrogenix Information Strategies
Sector Medical Products
Buyer(s) Certara
Deal Type Add-on Acquisition

Target

Synchrogenix Information Strategies

Wilmington, Delaware, United States
website
Synchrogenix partners with pharmaceutical and biotech companies to develop submission documents for global regulatory agencies.

Search 193,711 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Certara

Princeton, New Jersey, United States

website

Category Company
Founded 2008
Sector Life Science
Employees846
Revenue 244M USD (2020)
DESCRIPTION

Certara engages in model-informed drug development and regulatory science, focused on optimizing drug development and improving health outcomes. Certara was founded in 2008 and is headquartered in Princeton, New Jersey.

DEAL STATS #
Overall 2 of 10
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 2 of 10
State (Delaware) 1 of 1
Country (United States) 2 of 6
Year (2014) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-08-12 Great Lakes Drug Development

Brighton, Michigan, United States

Great Lakes Drug Development, Inc. is a provider of strategic, operational and interim management support for early drug development projects.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-12-01 XenologiQ

Canterbury, United Kingdom

XenologiQ is a quantitative systems pharmacology (QSP) consultancy provider.

Buy -
Mergr

Product

Company

Legal